Growth Metrics

Sarepta Therapeutics (SRPT) Change in Inventory (2016 - 2025)

Sarepta Therapeutics has reported Change in Inventory over the past 10 years, most recently at -$18.5 million for Q4 2025.

  • For Q4 2025, Change in Inventory fell 111.43% year-over-year to -$18.5 million; the TTM value through Dec 2025 reached $301.1 million, down 23.81%, while the annual FY2025 figure was $301.1 million, 23.81% down from the prior year.
  • Change in Inventory for Q4 2025 was -$18.5 million at Sarepta Therapeutics, down from $83.0 million in the prior quarter.
  • Over five years, Change in Inventory peaked at $177.4 million in Q1 2025 and troughed at -$18.5 million in Q4 2025.
  • A 5-year average of $48.9 million and a median of $27.0 million in 2021 define the central range for Change in Inventory.
  • Biggest five-year swings in Change in Inventory: soared 19675.16% in 2024 and later crashed 111.43% in 2025.
  • Year by year, Change in Inventory stood at $27.3 million in 2021, then plummeted by 67.43% to $8.9 million in 2022, then surged by 959.73% to $94.1 million in 2023, then soared by 71.79% to $161.7 million in 2024, then tumbled by 111.43% to -$18.5 million in 2025.
  • Business Quant data shows Change in Inventory for SRPT at -$18.5 million in Q4 2025, $83.0 million in Q3 2025, and $59.2 million in Q2 2025.